Better late than never? Experience with intravenous pamidronate treatment in patients with low bone mass or fractures following cadiac or liver transplantation

Osteoporosis International

Volumn 14, Issue 1, 2003, Pages 82-89

  Dodidou, P ^a   Bruckner, T ^a   Hosch, S ^a   Haass, M ^a   Klar, E ^a   Sauer, P ^a   Ziegler, R ^a   Leidig Bruckner, G ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Bisphosphonate; Bone mass; Fractures; Osteoporosis; Transplantation

Indexed keywords

AZATHIOPRINE; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; CYCLOSPORIN A; GLUCOCORTICOID; PAMIDRONIC ACID; VITAMIN D;

ADULT; ARTICLE; BIOCHEMISTRY; BONE MASS; BONE METABOLISM; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FRAGILITY FRACTURE; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER TRANSPLANTATION; MALE; OSTEOLYSIS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SIDE EFFECT;

ADULT; BONE DENSITY; DIPHOSPHONATES; DRUG ADMINISTRATION SCHEDULE; FEMALE; FEMUR NECK; FOLLOW-UP STUDIES; FRACTURES, BONE; HEART TRANSPLANTATION; HUMANS; INFUSIONS, INTRAVENOUS; LIVER TRANSPLANTATION; LUMBAR VERTEBRAE; MALE; MIDDLE AGED; OSTEOPOROSIS;

EID: 0346144492     PISSN: 0937941X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00198-002-1315-x     Document Type: Article

References (35)

1. Van Cleemput J, Daenen W, Nijs J, Geusens P, Dequeker J, Vanhaecke J (1995) Timing and quantification of bone loss in cardiac transplant recipients. Transplant Int 8: 196-200
2. Shane E, Rivas M, McMahon DJ et al. (1997) Bone loss and turnover after cardiac transplantation. J Clin Endocrinol Metab 82: 1497-1506
3. Rozenberg S, Oberlin F, Dorent R et al. (1995) Study of bone mineral density after cardiac transplantation. Transplant Proc 27: 1692-1693
4. Muchmore JS, Cooper DK, Ye Y, Schlegel VT, Zuhdi N (1991) Loss of vertebral bone density in heart transplant patients. Transplant Proc 23: 1184-1185
5. Sambrook PN, Kelly PJ, Keogh AM et al. (1994) Bone loss after heart transplantation: a prospective study. J Heart Lung Transplant 13: 116-121
6. Henderson NK, Sambrook PN, Kelly PJ et al. (1995) Bone mineral loss and recovery after cardiac transplantation. Lancet 346: 905
7. McDonald JA, Dunstan CR, Dilworth P et al. (1991) Bone loss after liver transplantation. Hepatology 14: 613-619
8. Meys E, Fonatanges E, Fourcade N, Thomasson A, Pouyet M, Delmas PD (1994) Bone loss after orthotopic liver transplantation. Am J Med 97: 445-450
9. Hawkins FG, Leon M, Lopez MB et al. (1994) (Bone loss and turnover in patients with liver transplantation. Hepatogastroenterology 41: 158-161
10. Eastell R, Dickson ER, Hodgson SF et al. (1991) Rates of vertebral bone loss before and after liver transplantation in women with primary biliary cirrhosis. Hepatology 14: 296-300
11. Shane E, Rivas M, Staron RB et al. (1996) Fracture after cardiac transplantation: a prospective longitudinal study. J Clin Endocrinol Metab 81: 1740-1746
12. Porayko MK, Wiesner RH, Hay JE et al. (1991) Bone disease in liver transplant recipients: incidence, timing and risk factors. Transplant Proc 23: 1462-1465
13. Leidig-Bruckner G, Hosch S, Dodidou P et al. (2001) Frequency and predictors of osteoporotic fractures after cardiac or liver transplantation: a follow up study. Lancet 357: 342-347
14. Thiébaud D, Krieg MA, Gillard-Berguer D, Jacquet AF, Goy JJ, Burckhardt P (1996) Cyclosporine induces high bone turnover and may contribute to bone loss after heart transplantation. Eur J Clin Invest 26: 549-555
15. Liberman UA, Weiss SR, Broll J et al. (1995) Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group. N Engl J Med 333: 1437-1443
16. Harris ST, Watts NB, Genant HK et al. (1999) Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized, controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group. JAMA 282: 1344-1352
17. Adachi JD, Bensen WG, Brown J et al. (1997) Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis. N Engl J Med 337: 382-387
18. Saag KG, Emkey R, Schnitzer TJ et al. (1998) Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group. N Engl J Med 339: 292-299
19. Black DM, Cummings SR, Karpf DB et al. (1996) Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group. Lancet 348: 1535-1541
20. Sambrook P, Birmingham J, Kelly P et al. (1993) Prevention of corticosteroid osteoporosis: a comparison of calcium, calcitriol and calcitonin. N Engl J Med 328: 1747-1752
21. 3, supplementation prevents bone loss in the spine secondary to low-dose corticosteroids in patients with rheumatoid arthritis: a randomized, double blind, placebo-controlled trial. Ann Intern Med 125: 961-968
22. McClung MR (1999) Therapy for fracture prevention. JAMA 282: 687-689
23. Kanis JA, Melton LJ III, Christiansen C, Johnston CC, Khaltaev N (1994) The diagnosis of osteoporosis. J Bone Miner Res 9: 1137-1141
24. Scheidt-Nave C, Felsenberg D, Kragl G et al. (1998) Vertebrale Deformität als Index der osteoporotischen Wirbelkörperfrakturen - eine externe Konstruktvalidierung anhand von Knochendichtemeßdaten. Med Klin 93(Suppl 2): 46-55
25. Dequeker J, Pearson J, Reeve J et al. (1995) Dual-X-ray absorptiometry: cross-calibration and normative reference ranges for the spine. Results of a European Community Concerted Action. Bone 17: 247-254
26. Pearson J, Dequeker J, Reeve J et al. (1995) Dual-X-ray absorptiometry of the proximal femur: normal European values standardized with the European Spine Phantom. J Bone Miner Res 10: 315-324
27. Leidig-Bruckner G, Limberg B, Felsenberg D et al. (2000) Sex difference in the validity of vertebral deformities as an index of prevalent vertebral osteoporotic fractures: a population survey of older men and women. Osteoporos Int 11: 102-109
28. Krieg MA, Seydoux C, Sandini L et al. (2001) Intravenous pamidronate as treatment for osteoporosis after heart transplantation: a prospective study. Osteoporos Int 12: 112-116
29. Shane E, Rodino MA, McMahon DJ et al. (1998) Prevention of bone loss after heart transplantation with antiresorptive therapy: a pilot study. J Heart Lung Transplant 17: 1089-1096
30. Fan S, Almond MK, Ball E, Evans K, Cunningham J (2000) Pamidronate therapy as prevention of bone loss following renal transplantation. Kidney Int 57: 684-690
31. Trombetti A, Gerbase MW, Spiliopoulos A, Slosman DO, Nicod LP, Rizzoli R (2000) Bone mineral density in lungtransplant recipients before and after graft: prevention of lumbar spine post-transplantation-accelerated bone loss by pamidronate. J Heart Lung Transplant 19: 736-743
32. Van Cleemput J, Daenen W, Geusens P, Dequeker J, van de Werf F, Vanhaecke J (1996) Prevention of bone loss in cardiac transplant recipients. A comparison of biphosphonates and vitamin D. Transplantation 61: 1495-1499
33. Riemens SC, Oostdijk A, van Doormaal JJ et al. (1996) Bone loss after liver transplantation is not prevented by cyclical etidronate, calcium and alphacalcidol. Osteoporos Int 6: 213-218
34. Henderson K, Eisman J, Keogh A et al. (2001) Protective effect of short-term calcitriol or cyclical etidronate on bone loss after cardiac or lung transplantation. J Bone Miner Res 16: 564-571
35. Sambrook P, Henderson NK, Keogh A et al. (2000) Effect of calcitriol on bone loss after cardiac or lung transplantation. J Bone Miner Res 15: 1818-1824